Cue Biopharma Inc
NASDAQ:CUE

Watchlist Manager
Cue Biopharma Inc Logo
Cue Biopharma Inc
NASDAQ:CUE
Watchlist
Price: 0.3374 USD 10.48% Market Closed
Market Cap: 26.6m USD

Operating Margin
Cue Biopharma Inc

-536.7%
Current
-1 980%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-536.7%
=
Operating Profit
-38.1m
/
Revenue
7.1m

Operating Margin Across Competitors

No Stocks Found

Cue Biopharma Inc
Glance View

Market Cap
26.2m USD
Industry
Biotechnology

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. The company is headquartered in Cambridge, Massachusetts and currently employs 57 full-time employees. The company went IPO on 2018-01-02. The firm is engineering a class of injectable biologics designed to selectively engage and modulate targeted T cells within the body to treat a range of cancers, chronic infectious diseases, and autoimmune diseases. The company has developed Immuno-STAT (Selective Targeting and Alteration of T Cells) platform, which harness an individual's intrinsic immune repertoire for restoring health while avoiding the deleterious side effects of broad immune activation (for immuno-oncology or infectious disease indications) or broad immune suppression (for autoimmunity and inflammation). The company has developed four biologic series within the Immuno-STAT platform, which includes CUE-100, CUE-200, CUE-300 and CUE-400, each specifically designed through rational protein engineering to possess distinct signaling modules for desired biological mechanisms to be applied across many diseases. CUE-101 is its advanced clinical stage asset.

CUE Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-536.7%
=
Operating Profit
-38.1m
/
Revenue
7.1m
What is the Operating Margin of Cue Biopharma Inc?

Based on Cue Biopharma Inc's most recent financial statements, the company has Operating Margin of -536.7%.

Back to Top